Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-03-23

FDA Approved: LORATADINE ALLERGY RELIEF — Supplemental Application (DISCOUNT DRUG MART)

View source ↗

Summary

The FDA approved a supplemental application for LORATADINE ALLERGY RELIEF from Discount Drug Mart, under an existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LORATADINE ALLERGY RELIEF (Loratadine)

Snippet

SUPPL AP for LORATADINE ALLERGY RELIEF (LORATADINE)